FIELD: medicine, pharmaceutics.
SUBSTANCE: present group of inventions refers to medicine, namely therapy and gastroenterology, and concerns treating functional gastrointestinal disturbances. That is ensured by administering a composition containing activated potentiated histamine, tumour necrosis factor alpha (TNF-α) and brain-specific protein S-100 antibodies.
EFFECT: administering such composition provides treating irritable bowel syndrome and other functional gastrointestinal disturbances ensured by normalising the motor-evacuation function of the large intestine.
12 cl, 4 ex, 4 tbl
